ClinVar Miner

Submissions for variant NM_006005.3(WFS1):c.1243_1245del (p.Val415del)

dbSNP: rs863224265
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000199829 SCV000252550 pathogenic not provided 2022-10-11 criteria provided, single submitter clinical testing Published functional studies demonstrate a damaging effect resulting in decreased wolframin expression compared to the wildtype (Rendtorff et al., 2011); In-frame deletion of 1 amino acid in a non-repeat region predicted to critically alter the protein; In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 21067485, 28432734, 16151413, 21446023, 15277431, 18806274, 21538838, 10521293, 21602428, 8808601, 27617222, 19042979, 23429432, 31600780)
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000611263 SCV000731608 pathogenic Rare genetic deafness 2017-04-14 criteria provided, single submitter clinical testing The p.Val415del variant in WFS1 has been reported in >10 individuals with Wolfra m syndrome (Hardy 1999, Smith 2004, Hansen 2005, Gasparin 2009, Chaussenot 2011, Rohayem 2011, Rendtorff 2011, de Heredia ML 2013, Bodoor 2016) and segregated i n 7 affected relatives (Hardy 1999, Hansen 2005, Gasparin 2009, Rendtorff 2011, Bodoor 2016). All of these individuals were homozygous or compound heterozygous. This variant has also been reported in ClinVar (Variation ID: 215406). This var iant was identified in 9/33582 Latino chromosomes by the Genome Aggregation Data base (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs750767821); however, its frequency is low enough to be consistent with a recessive carrier frequency. In addition, in vitro studies suggest that the p.Val415del variant may impact expr ession of WFS1 (Rendtorff 2011). In summary, this variant meets criteria to be c lassified as pathogenic for autosomal recessive Wolfram syndrome based upon repo rted familial cases, low frequency in controls, and functional evidence.
DASA RCV001849340 SCV002107143 pathogenic WFS1-Related Spectrum Disorders 2022-03-05 criteria provided, single submitter clinical testing Well-established in vitro or in vivo functional studies supportive of a damaging effect on the gene or gene product (PMID: 21538838) - PS3_supporting. This sequence change has been observed in affected individual(s) and ClinVar contains an entry for this variant (ClinVar ID: 215406; PMID: 27617222; PMID: 23429432; PMID: 19042979) - PS4. The variant is present at low allele frequencies population databases (rs863224265 – gnomAD 0.0008545%; ABraOM no frequency - http://abraom.ib.usp.br/) - PM2_supporting. The p.(Val415del) was detected in trans with a pathogenic variant (PMID: 27617222; PMID: 19042979) - PM3. Protein length variants as a result of in-frame deletions/insertions in a nonrepeat region or stop-loss variants - PM4. The variant co-segregated with disease in multiple affected family members (PMID: 27617222) - PP1. In summary, the currently available evidence indicates that the variant is pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV000199829 SCV002217148 pathogenic not provided 2024-08-08 criteria provided, single submitter clinical testing This variant, c.1243_1245del, results in the deletion of 1 amino acid(s) of the WFS1 protein (p.Val415del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs750767821, gnomAD 0.03%). This variant has been observed in individual(s) with autosomal recessive Wolfram syndrome (PMID: 10521293, 21067485, 27617222, 31600780). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 215406). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV002478696 SCV002799720 pathogenic Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome 2024-04-04 criteria provided, single submitter clinical testing
OMIM RCV001843422 SCV000044807 pathogenic Wolfram syndrome 1 2011-06-01 no assertion criteria provided literature only
PreventionGenetics, part of Exact Sciences RCV004541271 SCV004798201 pathogenic WFS1-related disorder 2024-02-23 no assertion criteria provided clinical testing The WFS1 c.1243_1245delGTC variant is predicted to result in an in-frame deletion (p.Val415del). This sequence variant has been documented to be causative for Wolfram syndrome (Hardy et al. 1999. PubMed ID: 10521293; Smith et al. 2004. PubMed ID: 15277431; Hansen et al. 2005. PubMed ID: 16151413; Gasparin et al. 2009. PubMed ID: 19042979; Marshall et al. 2013. PubMed ID: 23981289). This variant is reported in 0.026% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.